Floatz logo

Fragmin

Duodenal Cancer

Asan Medical CenterPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Duodenal Cancer cohort.

Asset / SponsorPhaseRating
N-BUTYL CYANOACRYLATE
Minia University
Phase 3B
Rivaroxaban
Asan Medical Center
Phase 2CCC
Cyclophosphamide
National Cancer Institute (NCI)
Phase 2CCC
Fludarabine
National Cancer Institute (NCI)
Phase 2CCC
PANTOPRAZOLE
Washington University School of Medicine
Phase 2CCC

View all 9 →

Same molecule, other indications

Fragmin is also rated in:

venous thromboembolismDormant
BBB
Indicative ·
73 / 100
View asset →
Veno-occlusive DiseaseDormant
BB
Indicative ·
65 / 100
View asset →
plasma cell myelomaDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →